Bugünkü hisse fiyatı Abbvie Inc. Common Stock (ABBV)

AbbVie Inc. is a global research biopharmaceutical company. Originally a research unit of Abbott Laboratories, it is a separate company since 2012. The main activity is research and development of new types of treatment for serious diseases. Humira, a drug intended for the treatment of rheumatoid arthritis, was launched in 2012. The company is also actively developing a cure for hepatitis C and more than 20 complex diseases.The company's shares are traded at New York Stock Exchange LLC.The company's market capitalization reaches 95.6 billion in dollars.